Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03282695

Ozone Therapy in Patients on Waiting List for Surgery Due to Disc Herniation: Prospective, Post-authorization Study

The main objective of this study is to estimate the cost-effectiveness of ozone therapy in patients on the waiting list for surgery due to disc herniation.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dr. Negrin University Hospital

Las Palmas de Gran Canaria, Las Palmas, 35019, Spain

About this study

A cohort study (patients on the waiting list for surgery due to herniated disc) will be carried out, to which the treatment with ozone will be offered, without giving up the planned surgical intervention.

The main objective of this prospective, post-authorization follow-up study is to estimate the cost-effectiveness of ozone therapy (compared to standard care) in patients with disc herniation waiting for surgery (by microdiscectomy). Besides utilities of patients with disc herniation on a waiting list for surgery will be estimated, social/economic burden of disc herniation will be quantified and a decision aid will be developed and applied.

The main outcome measures are "Direct hospital cost", "Percentage of executed surgeries" and "Change in sciatic pain". In addition, data on health-related quality of life and resource utilization will be collected which will permit to estimate the incremental cost-effectiveness ratio (ICER), comparing incremental costs and quality adjusted life years (QALY).

The variables will be collected at the beginning, on the day of treatment and at 1, 3, 6, 12 and 24 months. The enrollment period will be 24 months. The follow-up period will be 24 months.

The results of the study will allow a better understanding of the value of ozone therapy in the management of patients on the waiting list for herniated disc surgery. In addition, it will contribute to the development of a more patient-centered health system.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with a herniated and not calcified lumbar disc that presents as: not migrated protrusion and/or extrusion.
  • Evaluated and diagnosed by the Neurosurgery Department, having been chosen as an appropriate candidate for surgery consisting in discectomy or microdiscectomy, after meeting the following two criteria: 1) Sciatic pain, with a visual analogue scale (VAS) intensity ≥ 5, despite 6 weeks of conservative management, wether it exists lumbar pain or not and 2) Radiating pain that matches the MRI image showing one or more herniated discs (not to be considered those patients with two herniated discs and symptoms attributable to only one of the herniated discs).
  • Included in the surgery waiting list for a discectomy or microdiscectomy.
  • Patients who have signed and dated the study 's specific informed consent.

Exclusion criteria

  • Patients who do not meet all the inclusion criteria.
  • Calcified and/or migrated herniated disc, and/or with a severe neurological deficits (cauda equine syndrome).
  • Herniated disc with surgical indication of laminectomy and/or arthrodesis (massive extrusion, sign of instability or other conditions under the neurosurgeon judgment).
  • Relevant clinical paresis that does not improve despite 6 weeks of full conservative management (patients with severe pain and mild paresis that only shows up in the physical exam are not to be excluded, but those who present with paresis as the main symptom -"clinically relevant"- must be).
  • Simultaneous symptomatic cervical or dorsal herniated discs.
  • Previous lumbar spine surgery.
  • Concomitant spine conditions that may be causing symptoms or have indication for surgery (such as fractures or tumors).
  • Known allergy to ozone.
  • Those who are uncapable to fill in the scales used to measure variables in the study, like the visual analogue scale (VAS), Roland-Morris and SF-12 questionnaires.
  • Those who are unable or do not wish to fulfill the study 's protocol (answer questions to collect the data).

Treatment and study plan

Primary outcomes

  1. Direct Hospital Cost for patients included on waiting list for surgery due to disc herniation.

    Time frame: 24 months

    Euros

  2. Percentage of surgeries finally performed.

    Time frame: 24 months

    Percentage of surgeries performed after enrollment

  3. Change from Baseline in sciatic pain at 12 months

    Time frame: 12 months

    Visual Analogic Scale (VAS)

  4. Change from Baseline in sciatic pain at 24 months

    Time frame: 24 months

    Visual Analogic Scale (VAS)

Secondary outcomes

  1. Change from Baseline in sciatic pain at 6 months

    Time frame: 6 months

    Visual Analogic Scale (VAS)

  2. Change from Baseline in lumbar pain at 6 months

    Time frame: 6 months

    Visual Analogic Scale (VAS)

  3. Change from Baseline in lumbar pain at 12 months

    Time frame: 12 months

    Visual Analogic Scale (VAS)

  4. Change from Baseline in lumbar pain at 24 months

    Time frame: 24 months

    Visual Analogic Scale (VAS)

  5. Number of hospital stay days

    Time frame: 24 months

    Number of hospital stay days

  6. Restriction of everyday activities

    Time frame: 24 months

    Spanish version of Roland-Morris questionnaire

  7. Quality of life by 12-Item Short Form Survey (SF-12)

    Time frame: 24 months

    SF-12 questionnaire

  8. Quality of life by the five-level version of the EuroQol five-dimensional (EQ-5D-5L) questionnaire

    Time frame: 24 months

    EQ-5D-5L questionnaire

  9. Loss of labour productivity

    Time frame: 24 months

    Off work days (if applicable)

  10. Time to resume normal activity

    Time frame: 24 months

    Days

  11. Direct sanitary and non-sanitary costs incurred out of hospital.

    Time frame: 24 months

    Euros

  12. Adverse effects

    Time frame: 24 months

    Number of serious adverse effects

  13. Time from inclusion on waiting list for surgery to completion of the procedure.

    Time frame: 24 months

    Days

Sponsors and collaborators

Lead sponsor

Bernardino Clavo, MD, PhD

Other

Collaborators

  • Colegio Oficial de Médicos de Las Palmas
  • Instituto de Salud Carlos III
  • Red de Investigación en Servicios de Salud en Enfermedades Crónicas
  • Servicio Canario de Salud

Registry information

Acronym: O3HDCIRUGIA

Important dates

Study start
2018
Primary completion
2023
Study completion
2026
First posted
Sep 14, 2017
Registry last updated
Mar 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.